Chronic liver diseases: current therapeutic options.
Kaplan
M M
MM
Tufts University School of Medicine, Boston.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D001379:Azathioprine / Q000627:therapeutic use; D015209:Cholangitis, Sclerosing / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D002908:Chronic Disease; D003078:Colchicine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D006509:Hepatitis B / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D006526:Hepatitis C / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D006521:Hepatitis, Chronic / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use; D008105:Liver Cirrhosis, Biliary / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D008107:Liver Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D008727:Methotrexate / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D007370:Interferon Type I; D001379:Azathioprine; D003078:Colchicine; D008727:Methotrexate